Table 5.
Variable | Type 2 diabetes with MCI | Type 2 diabetes without MCI | Z/t | P value |
---|---|---|---|---|
Adiponectin (μg/ml) | ||||
BMI ≤ 25.9 | 13.04 ± 3.98 | 13.5 ± 3.83 | 0.27 | 0.78 |
BMI 26–27.9* | 9.37 ± 3.33 | 11.76 ± 3.05 | 2.68 | 0.009 |
BMI 28–29.9* | 6.14 ± 2.85 | 10.38 ± 2.77 | 4.34 | <0.001 |
BMI ≥ 30* | 2.89 ± 1.59 | 5.44 ± 3.78 | 3.39 | 0.001 |
Leptin (ng/ml) | ||||
BMI ≤ 25.9 | 7.6 ± 2.94 | 8.4 ± 5.28 | 0.32 | 0.74 |
BMI 26–27.9* | 19.29 ± 5.0 | 15.6 ± 5.43 | −2.43 | 0.017 |
BMI 28–29.9* | 21.76 ± 8.65 | 17.94 ± 3.34 | −2.11 | 0.04 |
BMI ≥ 30* | 32.98 ± 11.5 | 27.03 ± 7.31 | −2.51 | 0.014 |
IL-1 β (ng/ml) | ||||
BMI ≤ 25.9* | 8.82 ± 0.71 | 6.6 ± 2.23 | −2.16 | 0.04 |
BMI 26–27.9 | 9.4 ± 0.75 | 9.27 ± 1.47 | −0.33 | 0.73 |
BMI 28–29.9* | 13.56 ± 3.44 | 9.96 ± 1.18 | −5.17 | <0.001 |
BMI ≥ 30* | 21.97 ± 1.51 | 16.09 ± 8.6 | −2.94 | 0.004 |
*significance, p < 0.05
MCI mild cognitive impairment, BMI body mass index. Data are mean – SD values. Mann–Whitney U test (Z), or t test was used to test for significant differences